Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19
…, BJ McVerry, CCH Chang, E Leifer, C Bradbury… - Jama, 2023 - jamanetwork.com
Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …
Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus …
Introduction Immune thrombocytopenia (ITP) is an autoimmune condition that may cause
thrombocytopenia-related bleeding. Current first-line ITP treatment is with high-dose …
thrombocytopenia-related bleeding. Current first-line ITP treatment is with high-dose …
[HTML][HTML] Residual disease detection by flow cytometry predicts risk of relapse and overall survival in patients with Acute Myeloid Leukemia following reduced intensity …
CA Bradbury, J Ward, P Vyas, NH Russell, G David… - Blood, 2012 - Elsevier
Abstract 4098 Relapse after allogeneic hematopoietic cell transplantation (HCT) is usually
incurable for acute myeloid leukemic (AML) patients. Residual disease (MRD) monitoring pre- …
incurable for acute myeloid leukemic (AML) patients. Residual disease (MRD) monitoring pre- …
[BOOK][B] Medieval women and their objects
J Adams, N Bradbury - 2021 - books.google.com
The essays gathered in this volume present multifaceted considerations of the intersection of
objects and gender within the cultural contexts of late medieval France and England. Some …
objects and gender within the cultural contexts of late medieval France and England. Some …
Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report (preprint)
Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized
that therapeutic anticoagulation would improve outcomes in critically ill patients with …
that therapeutic anticoagulation would improve outcomes in critically ill patients with …
[HTML][HTML] Lower Levels of Circulating Endothelial Progenitor Cells Are Associated with Increased Recurrence after Unprovoked Venous Thrombosis
CA Bradbury, T Buckley, K Fletcher, P Rose… - Blood, 2016 - Elsevier
Introduction: Endothelial progenitor cells (EPCs) are multipotent progenitor cells mainly
residing in human bone marrow. In response to stimuli such as arterial ischaemia or venous …
residing in human bone marrow. In response to stimuli such as arterial ischaemia or venous …
[PDF][PDF] Julie Pell, Rosemary Greenwood, 2 Jenny Ingram, 2 Katherine Wale, 3 Ian Thomas, Rebecca Kandiyali, 3 Andrew Mumford, 4, 5 Andrew Dick, 4, 6 Catherine …
N Cooper, Q Hill, CA Bradbury - academia.edu
Introduction Immune thrombocytopenia (ITP) is an autoimmune condition that may cause
thrombocytopeniarelated bleeding. Current first-line ITP treatment is with high-dose …
thrombocytopeniarelated bleeding. Current first-line ITP treatment is with high-dose …
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19 (preprint)
…, AF Turgeon, J Escobedo, DT Huang, CA Bradbury… - 2021 - pesquisa.bvsalud.org
BackgroundThrombo-inflammation may contribute to morbidity and mortality in Covid-19.
We hypothesized that therapeutic-dose anticoagulation may improve outcomes in non-critically …
We hypothesized that therapeutic-dose anticoagulation may improve outcomes in non-critically …
Security in old age for older single women without children
… We also thank Richard Webb at CPA Australia for his useful feedback on the draft report,
and Ann-Charlotte Stent and Glenn Howell for their excellent support with copyediting and …
and Ann-Charlotte Stent and Glenn Howell for their excellent support with copyediting and …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
…, A Beane, S Berry, Z Bhimani, M Bonten, C Bradbury… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …